We previously reported that MK mRNA expression in tumour specimens is very high at all human neuroblastoma stages, including stage 4S, as compared with that in benign tumours, that is, ganglioneuromas (Nakagawara et al, 1995). This evidence concerns the gene MDK and neoplasm.